Journal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
Volume 17, Issue 9, Pages 529-530Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41575-020-0333-5
Keywords
-
Categories
Ask authors/readers for more resources
The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of viruses as modulators of mucosal immunity and as treatment-related safety hazards, and the current clinical evidence will be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
